Richard Lim

Chief Executive Officer at

Xenimmune Therapeutics, Inc.

54 year

96 connections

Health Technology

Finance

Consumer Services

Profile

Richard J.
Lim is the founder of Cure Ventures Management LP, founded in 2021, where the title held is Managing Partner.
Current jobs include Chief Executive Officer & Director at Xenimmune Therapeutics, Inc., and Catalyst Advisory at Massachusetts Institute of Technology.
Former jobs include Director at Spherics, Inc., HydroCision, Inc., Trident Pharmaceuticals, Inc., Gossamer Bio, Inc., and Nuvation Bio Operating Co., Inc.; Managing Director at Omega Fund Management LLC from 2008 to 2020; Independent Director at Paratek Pharmaceuticals, Inc. from 2014 to 2018; Vice President at Saunders Karp & Megrue Partners LLC; Manager at The Lek; General Partner at MVM Partners LLP from 2002 to 2008; Associate at Wolfensohn & Co., Inc.; and Member-Executive Board at Danish BioVenture General Partner ApS.
Education includes undergraduate degree from Harvard University in 1993 and MBA from Harvard Business School in 1998.

Richard Lim active positions

Companies	Position	Start
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Corporate Officer/Principal	-
Cure Ventures Management LP Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments.	Founder	01/07/2021
Xenimmune Therapeutics, Inc. Xenimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody-enzyme fusion to target tumors and trigger the hyper-acute rejection	Chief Executive Officer	-

All active positions of Richard Lim

Former positions of Richard Lim

Companies	Position	End
Danish BioVenture General Partner ApS Danish BioVenture General Partner ApS Financial ConglomeratesFinance Operates as a general partner and renders investment advice to K/S Danish BioVenture	Director/Board Member	-
Omega Fund Management LLC Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments.	Private Equity Investor	01/01/2020
GOSSAMER BIO, INC.	Director/Board Member	19/12/2018
PARATEK PHARMACEUTICALS, INC.	Director/Board Member	11/04/2018
Spherics, Inc. Spherics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Director/Board Member	07/01/2010

See the detail of Richard Lim's experience

Training of Richard Lim

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Lim's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	17
Spherics, Inc. Spherics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
HydroCision, Inc. HydroCision, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets fluid-jet based surgical tools	Health Technology
Trident Pharmaceuticals, Inc. Trident Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel biologics for the treatment of autoimmune disorders	Health Technology
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Saunders Karp & Megrue Partners LLC Saunders Karp & Megrue Partners LLC Financial ConglomeratesFinance Private equity firm	Finance
The Lek/Alcar Consulting Group, Inc. The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services	Commercial Services
MVM Partners LLP MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm focuses on healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million.	Finance
Wolfensohn & Co., Inc. Wolfensohn & Co., Inc. Investment Banks/BrokersFinance Provides investment banking and financial advisory services	Finance
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
Omega Fund Management LLC Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments.	Finance
Danish BioVenture General Partner ApS Danish BioVenture General Partner ApS Financial ConglomeratesFinance Operates as a general partner and renders investment advice to K/S Danish BioVenture	Finance
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Paratek Pharmaceuticals, Inc. Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Health Technology
Gossamer Bio, Inc. Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases	Health Technology
Nuvation Bio Operating Co., Inc. Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates	Health Technology
Cure Ventures Management LP Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments.	Finance
Xenimmune Therapeutics, Inc. Xenimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody-enzyme fusion to target tumors and trigger the hyper-acute rejection	Health Technology